Partner, Executive Search
Ken Dropiewski serves as a Partner at McDermott + Bull and is part of the firm’s national MedTech and Life Sciences Group. While he serves the entire Medical Device and Biotechnology industry, Ken is particularly well known for his work within the cardiac, vascular, interventional, and oncology segments.
Ken has been in the Medtech industry for over 25 years. Prior to Ken’s career in executive search, he held various commercial roles within Johnson & Johnson and Boston Scientific, in which he won several acclaimed awards including Ring Club, Grand Awards, and President’s Club. He was the founder and President of Prime-Core Executive Search, a boutique search firm that was formed in 2003 to serve the Medical Device and Biotech industries. During his tenure at Prime-Core, Ken quickly earned the respect of some of the most notable companies in the industry, performing search work for companies like Medtronic and Boston Scientific, as well as some of the most innovative high growth small and mid-cap companies within the space. In 2018, Ken moved Prime-Core’s practice over to McDermott + Bull to better serve his clients and increase his reach. His particular focus is small to mid-cap growth companies, both private and public.
Ken holds a Bachelor of Science in finance from Central Michigan University and an MBA from the University of Colorado in Denver, with a focus on entrepreneurial studies and leadership development.
MedTech + Life Sciences Videos
McDermott + Bull has successfully placed Betsy Brookes as Vice President of Human Resources at RapidAI. Working closely with the Chief Executive Officer and leadership team, Betsy will be the go-to person for all strategic business-related issues with HR implications....
McDermott + Bull has successfully placed Karim Karti as Chief Executive Officer at RapidAI. Karim will refine and advance the company’s objectives around top growth, acquisitions, margin expansion, operational efficiency, and organization development. He will provide...
McDermott + Bull has successfully placed Matt Byrne as Vice President of R+D and Operations at Francis Medical. In this role, Matt will deliver significant design and operating improvements to ensure that the company consistently meets or exceeds quality standards in...
Check out McDermott + Bull Managing Director Ken Dropiewski’s series, Investor Insights in Life Sciences + MedTech, where he profiles some of the top investment professionals in this space. Stay tuned for more to come!
What matters to you, matters to us.
WE’RE PRO YOU.